Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA
source: pixabay.com

Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA

According to a story from prnewswire.com, the Chiesi Global Rare Diseases and the biopharmaceutical company ProTalix Biotherapeutics have recently announced that they have submitted a Biologics License Application (BLA) for…

Continue Reading Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA

An App in New Zealand Allows IBD Patients to Communicate with Their Specialists Virtually

IBDsmart Researchers at the University of Otago, led by Michael Shultz, have developed a new app called IBDsmart to help patients with ulcerative colitis or Crohn's disease receive care remotely.…

Continue Reading An App in New Zealand Allows IBD Patients to Communicate with Their Specialists Virtually
Study Identifies Bronchiectasis Risk Factors in Aspirin-Exacerbated Respiratory Disease
source: pixabay.com

Study Identifies Bronchiectasis Risk Factors in Aspirin-Exacerbated Respiratory Disease

According to a story from Pulmonology Advisor, a recent study has evaluated risk factors for the appearance of bronchiectasis in patients with aspirin-exacerbated respiratory disease (AERD). A small number of…

Continue Reading Study Identifies Bronchiectasis Risk Factors in Aspirin-Exacerbated Respiratory Disease